FDA asks experts if pain drugs get second chance

WASHINGTON (Reuters) - U.S. drug regulators are asking experts for advice on whether companies should restart clinical trials for painkillers that help people with osteoarthritis and other conditions, but can destroy joints.

heart to hand quilt shop sferra sheets blanket contractual